全文获取类型
收费全文 | 3522篇 |
免费 | 290篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 56篇 |
儿科学 | 124篇 |
妇产科学 | 38篇 |
基础医学 | 415篇 |
口腔科学 | 110篇 |
临床医学 | 379篇 |
内科学 | 1026篇 |
皮肤病学 | 53篇 |
神经病学 | 326篇 |
特种医学 | 87篇 |
外国民族医学 | 14篇 |
外科学 | 456篇 |
综合类 | 35篇 |
一般理论 | 1篇 |
预防医学 | 250篇 |
眼科学 | 44篇 |
药学 | 215篇 |
中国医学 | 9篇 |
肿瘤学 | 179篇 |
出版年
2022年 | 23篇 |
2021年 | 54篇 |
2020年 | 26篇 |
2019年 | 43篇 |
2018年 | 61篇 |
2017年 | 31篇 |
2016年 | 41篇 |
2015年 | 48篇 |
2014年 | 81篇 |
2013年 | 135篇 |
2012年 | 133篇 |
2011年 | 180篇 |
2010年 | 111篇 |
2009年 | 95篇 |
2008年 | 164篇 |
2007年 | 192篇 |
2006年 | 198篇 |
2005年 | 212篇 |
2004年 | 168篇 |
2003年 | 208篇 |
2002年 | 168篇 |
2001年 | 40篇 |
2000年 | 46篇 |
1999年 | 37篇 |
1998年 | 49篇 |
1997年 | 33篇 |
1996年 | 31篇 |
1995年 | 35篇 |
1994年 | 42篇 |
1993年 | 34篇 |
1992年 | 29篇 |
1991年 | 34篇 |
1989年 | 24篇 |
1988年 | 29篇 |
1987年 | 31篇 |
1986年 | 29篇 |
1985年 | 50篇 |
1984年 | 47篇 |
1983年 | 60篇 |
1982年 | 68篇 |
1981年 | 68篇 |
1980年 | 64篇 |
1979年 | 37篇 |
1978年 | 45篇 |
1977年 | 45篇 |
1976年 | 41篇 |
1975年 | 48篇 |
1974年 | 40篇 |
1973年 | 38篇 |
1972年 | 21篇 |
排序方式: 共有3817条查询结果,搜索用时 15 毫秒
41.
Patricia J Eifel Kathryn Winter Mitchell Morris Charles Levenback Perry W Grigsby Jay Cooper Marvin Rotman David Gershenson David G Mutch 《Journal of clinical oncology》2004,22(5):872-880
PURPOSE: To report mature results of a randomized trial that compared extended-field radiotherapy (EFRT) versus pelvic radiotherapy with concomitant fluorouracil and cisplatin (CTRT) in women with locoregionally advanced carcinomas of the uterine cervix. PATIENTS AND METHODS: Four hundred three women with cervical cancer were randomly assigned to receive either EFRT or CTRT. Patients were eligible if they had stage IIB to IVA disease, stage IB to IIA disease with a tumor diameter > or = 5 cm, or positive pelvic lymph nodes. Patients were stratified by stage and by method of lymph node evaluation. RESULTS: The median follow-up time for 228 surviving patients was 6.6 years. The overall survival rate for patients treated with CTRT was significantly greater than that for patients treated with EFRT (67% v 41% at 8 years; P <.0001). There was an overall reduction in the risk of disease recurrence of 51% (95% CI, 36% to 66%) for patients who received CTRT. Patients with stage IB to IIB disease who received CTRT had better overall and disease-free survival than those treated with EFRT (P <.0001); 116 patients with stage III to IVA disease had better disease-free survival (P =.05) and a trend toward better overall survival (P =.07) if they were randomly assigned to CTRT. The rate of serious late complications of treatment was similar for the two treatment arms. CONCLUSION: Mature analysis confirms that the addition of fluorouracil and cisplatin to radiotherapy significantly improved the survival rate of women with locally advanced cervical cancer without increasing the rate of late treatment-related side effects. 相似文献
42.
Ranjana Advani George A Fisher Bert L Lum Charro Jambalos Cheryl D Cho Marvin Cohen Ashwin Gollerkeri Branimir I Sikic 《Clinical cancer research》2003,9(14):5187-5194
PURPOSE: The purpose of this study was to establish the maximum tolerated dose (MTD), dose-limiting toxicities (DLTs), and preliminary activity of BMS-188797 administered weekly. EXPERIMENTAL DESIGN: Patients with advanced malignancies were treated with escalating doses of BMS-188797 on a weekly schedule as a 1-h i.v. infusion. Plasma sampling was performed to characterize the pharmacokinetics of BMS-188797. RESULTS: Eighteen patients with advanced malignancies were enrolled at three dose levels ranging from 35 to 65 mg/m(2). The number of patients evaluated at each dose level was as follows: 35 mg/m(2) (n = 3); 50 mg/m(2) (n = 9); and 65 mg/m(2) (n = 6). At 65 mg/m(2), three of six patients had a DLT (one had grade 4 neutropenia lasting >7 days, and two had grade 3 diarrhea). Expansion of the 50-mg/m(2) dose cohort to nine patients established this dose as the MTD, with one patient experiencing a DLT (grade 4 neutropenia with fever). Two partial responses were observed (lung cancer, 7+ months; ovarian cancer, 6+ months durations), as well as two minor responses (esophageal cancer, 5 months; ovarian cancer, 5 months). Both patients with partial responses had been clinically resistant to paclitaxel. Plasma pharmacokinetic mean values of maximum concentration (C(max)) and area under the curve (AUC(0-48)) increased in a dose-dependent manner within the range of doses used in this study, and in three of four patients, the DLTs correlated with AUC. CONCLUSIONS: The MTD and the recommended Phase II dose of weekly BMS-188797 is 50 mg/m(2). The drug demonstrates antitumor activity in taxane-refractory solid tumors and is now being evaluated in combination with carboplatin. 相似文献
43.
Arthur M. Lauretano Kasey K. Li David S. Caradonna Rohit K. Khosta Marvin P. Fried 《The Laryngoscope》1997,107(8):1057-1059
Knowledge of the location of the hypoglossal/lingual artery neurovascular bundle (HLNVB) is essential in performing tongue base resections for neoplasm and for obstructive sleep apnea. Transoral and transcervical resections of the tongue base may be performed with greater exposure and certainty when the relationship of the HLNVB to local landmarks is understood; knowledge of the HLNVB allows resection of a larger amount of contralateral tongue base during partial glossectomy without violating the contralateral remnant tongue's blood supply. Ten cadaver heads were dissected to determine the position of the HLNVB with respect to soft tissue and bony landmarks at the tongue base. Our results indicate the position of the tongue base HLNVB is significantly inferior and lateral, that is, 2.7 cm inferior and 1.6 cm lateral to the foramen cecum, 0.9 cm superior to the hyoid bone, and 2.2 cm medial to the mandible. This inferolateral location allows the potential for aggressive tongue base resection without neurovascular compromise. 相似文献
44.
45.
H2/CH4 ratios cannot reliably distinguish abiotic vs. biotic methane in natural hydrothermal systems
46.
Foot-and-mouth disease (FMD) is a highly-contagious livestock disease with global socioeconomic ramifications. The disease negatively impacts both individual farmers through reduced herd viability and nations through trade restrictions of animals and animal derivatives. Vaccines for FMD prevention have existed for over 70 years, yet the disease remains enzootic in a large percentage of the globe. FMD persistence is due in part to technical limitations of historic and current vaccine technologies. There also exist many socioeconomic and political barriers to global FMD eradication. Here we highlight the barriers to eradication and discuss potential avenues toward FMD eradication. 相似文献
47.
48.
49.